This article is more than 5 years old. Information may no longer be current.
Vanderbilt appoints hematology/oncology division director
Click Here to Manage Email Alerts
W. Kimryn Rathmell, MD, PhD, has been appointed director of Vanderbilt University Medical Center’s division of hematology and oncology.
Rathmell previously served as professor for translational science and associate director for training and education at Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill.
W. Kimryn Rathmell
“Vanderbilt is an institution that values and excels in translational research,” Rathmell said in a press release. “They are very strong clinically and they build on diverse strengths in the basic sciences, particularly in bringing innovative new therapies to the clinical arena.”
Rathmell’s research focuses on the genetic and molecular signals that drive renal cell carcinomas. She specializes in the treatment of patients with rare and complex kidney cancers, as well as prostate, bladder and testicular cancers. She will continue to care for patients with genitourinary malignancies in addition to continuing research in her laboratory at Vanderbilt-Ingram Cancer Center.
“Dr. Rathmell will bring with her a vibrant research program studying the molecular pathogenesis of renal cell carcinoma, as well as a passion for mentoring and developing the careers of faculty,” Nancy Brown, MD, professor of medicine and pharmacology and chair of the department of medicine at Vanderbilt, said in a press release.